Editorial foreword special issue "Hepatocellular Carcinoma - A Worldwide Translational Approach"

Cancer Letters

Volumn 286, Issue 1, 2009, Pages 3-4

  Plymoth, Amelie ^a   Chemin, Isabelle ^b   Boffetta, Paolo ^a   Hainaut, Pierre ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b INSERM   (France)

Author keywords

Biomarkers; Epidemiology; Hepatitis B and C viruses; Hepatocellular carcinoma; Molecular carcinogenesis; Therapeutic approaches

Indexed keywords

AFLATOXIN; ANTINEOPLASTIC AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE; PROTEIN P53; TUMOR MARKER;

CANCER GENE THERAPY; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CANCER RISK; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG EFFICACY; EARLY DIAGNOSIS; ETHNICITY; GENE EXPRESSION; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; MEDICAL ETHICS; MOLECULAR EPIDEMIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLICATION; QUALITY CONTROL; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SHORT SURVEY; STANDARDIZATION;

EID: 70350567173     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.03.002     Document Type: Review

References (0)